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ilopodia are dynamic F-actin structures that cells use
to explore their environment. c-Abl tyrosine kinase
promotes ﬁlopodia during cell spreading through an
unknown mechanism that does not require Cdc42 activity.
Using an unbiased approach, we identiﬁed Dok1 as a
speciﬁc c-Abl substrate in spreading ﬁbroblasts. When
activated by cell adhesion, c-Abl phosphorylates Y361 of
Dok1, promoting its association with the Src homology 2
domain (SH2)/SH3 adaptor protein Nck. Each signaling
component was critical for ﬁlopodia formation during
F
 
cell spreading, as evidenced by the ﬁnding that mouse
ﬁbroblasts lacking c-Abl, Dok1, or Nck had fewer ﬁlopodia
than cells reexpressing the product of the disrupted gene.
Dok1 and c-Abl stimulated ﬁlopodia in a mutually interde-
pendent manner, indicating that they function in the same
signaling pathway. Dok1 and c-Abl were both detected in
ﬁlopodia of spreading cells, and therefore may act locally
to modulate actin. Our data suggest a novel pathway by
which c-Abl transduces signals to the actin cytoskeleton
through phosphorylating Dok1 Y361 and recruiting Nck.
 
Introduction
 
Regulated cell migration is important for several biological
processes, including development, immune responses, neuron
function, and tissue repair. For migration to be productive, a
cell must first determine a direction of movement. To this end,
a cell explores its environment by extending elongated actin-
rich structures referred to as filopodia. Filopodia are extremely
dynamic, protruding and retracting from the cell perimeter
seeking guidance cues and adhesive proteins in the ECM
(Svitkina et al., 2003). Filopodia are abundant at the leading
edge of cells that are actively exploring their environment. For
example, filopodia are found on migrating sheets of embryonic
epithelial cells, spreading fibroblasts, axon growth cones, and
neuronal dendritic spines (Wood and Martin, 2002).
Actin polymerization provides the force to drive filopodial
membrane protrusions (Mallavarapu and Mitchison, 1999).
Current data suggest that filopodia arise from the elongation,
convergence, and bundling of preexisting actin filaments in
the lamellipod (Svitkina et al., 2003). WASP family proteins
regulate filopodia by recruiting the Arp2/3 complex, which
nucleates actin polymerization (Pollard and Borisy, 2003).
Although activators of WASP have been identified (e.g.,
Rho family GTPases, PIP
 
2
 
, and SH3 adaptor proteins), the
signaling pathways controlling the formation, maintenance,
and termination of filopodia during specific cellular processes
remain largely undefined.
Recent observations suggest that c-Abl tyrosine kinase can
regulate filopodia formation. c-Abl extends the duration of
membrane protrusive activity during the early stages of cell
spreading on fibronectin (FN), resulting in increased numbers
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of filopodia and F-actin microspikes (Woodring et al.,
2002), which are precursors to filopodia (Kozma et al.,
1995; Svitkina et al., 2003). Active Abl also increases the
length of neurites and the number of F-actin–rich branches
on embryonic cortical neurons grown on laminin (Zuker-
berg et al., 2000; Woodring et al., 2002). The effect of c-Abl
on neurite branching and persistence of filopodia during cell
spreading is dependent on c-Abl tyrosine kinase activity, im-
plicating c-Abl substrates in these processes. Indeed, cell ad-
hesion to ECM components, such as FN, collagen, vitronec-
tin, and laminin, increases c-Abl activity (Lewis et al., 1996;
Frasca et al., 2001; Woodring et al., 2001). Several collabo-
rators that synergize with c-Abl in F-actin–mediated pro-
cesses have been suggested (for review see Lanier and
Gertler, 2000; Woodring et al., 2003; Hernandez et al.,
2004); however, essential components downstream of c-Abl
remain elusive.
Here, we investigated the c-Abl substrates involved in the
persistence of F-actin microspikes and filopodia during fi-
broblast spreading. Using an unbiased biochemical strategy
to detect substrates combined with a genetic strategy using
fibroblasts from knockout mouse embryos, we found that
the p62 docking protein (Dok1) is an essential substrate for
c-Abl in the induction of filopodia during FN-stimulated
cell spreading. c-Abl and Dok1 are both present in filopodia,
supporting a role for both proteins in filopodia function.
The effects of c-Abl on filopodia appear to be mediated by
the phosphorylation of Y361 of Dok1, which promotes as-
sociation of Dok1 and Nck, a Src homology 2 domain
(SH2)/SH3 adaptor protein that can trigger localized actin
polymerization (Campellone et al., 2004; Rivera et al.,
2004).
 
Results
 
An unbiased approach for isolating c-Abl substrates
 
The Abl-SH2 domain was used as an affinity matrix to iso-
late c-Abl substrates involved in cell spreading. We chose
this strategy because it has been shown previously that the
Abl-SH2 domain binds to the phosphotyrosine (pTyr) in
known Abl substrates (Songyang et al., 1993; Duyster et al.,
1995; Mayer et al., 1995). We detected several pTyr-con-
taining proteins in lysates from spreading NIH3T3 fibro-
blasts that bound GST-Abl-SH2 (Abl-SH2), but not GST.
One group of proteins was in the 105–130-kD range and
another in the 
 
 
 
60-kD range (Fig. 1 A). The interaction of
these proteins with Abl-SH2 was dependent on cell adhe-
sion, which is consistent with the increase in c-Abl activity
observed during fibroblast spreading on FN (Lewis et al.,
1996).
We used four additional criteria to determine if any of
these pTyr-containing proteins were indeed c-Abl substrates.
First, we performed similar experiments using mouse em-
bryo fibroblasts (MEFs) null for both Abl and Arg (Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
). These MEFs were stably reconstituted with c-Abl
(Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
]) or pMSCV vector (pMSCV[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
]) using retroviral-mediated gene transfer. Signifi-
cantly lower levels of the 
 
 
 
60-kD pTyr-proteins were iso-
lated with Abl-SH2 using lysates from spreading pMSCV
[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs compared with Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
]
MEFs (Fig. 1 B, lanes 1 and 3). Second, we pretreated
spreading Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs with an inhibitor of
c-Abl kinase, signal transduction inhibitor (STI)571 (Schin-
dler et al., 2000). This treatment of cells with STI571 also
decreased the level of 
 
 
 
60-kD pTyr-proteins isolated with
Abl-SH2 (Fig. 1 B, lanes 3 and 4). Third, we used latruncu-
lin A, an inhibitor of F-actin assembly that can activate
c-Abl in suspended cells (Woodring et al., 2002). Latrunculin
treatment of suspended Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs increased
the level of 
 
 
 
60-kD pTyr-proteins that were isolated with
Abl-SH2 (Fig. 1 C, lanes 1 and 2). Finally, to explore the
specificity of the Abl-SH2 affinity method, we used 0.5 
 
 
 
M
SU6656, which inhibits the activity of c-Src, Fyn, and Lck
(Blake et al., 2000; the IC
 
50
 
 for Src kinases is 
 
 
 
0.3 
 
 
 
M,
whereas the IC
 
50
 
 for c-Abl is 1.7 
 
 
 
M). Addition of SU6656
to suspended latrunculin-treated MEFs did not cause a sig-
nificant decrease in the quantity of 
 
 
 
60-kD pTyr-proteins
isolated with Abl-SH2, whereas STI571 did (Fig. 1 C). Also,
the Src kinase inhibitor was less effective than the Abl inhib-
itor at reducing the amount of 
 
 
 
60-kD pTyr-proteins iso-
lated with Abl-SH2 from lysates of spreading cells (Fig. 1
D). Presumably, many of the 105–130-kD pTyr-proteins
are not substrates for c-Abl even though they are isolated
with Abl-SH2. In contrast, the 
 
 
 
60-kD pTyr-proteins ap-
peared to be good candidates for bona fide c-Abl substrates
during FN-stimulated cell adhesion and spreading because
Figure 1. pTyr-containing proteins associate with Abl-SH2 during 
FN-stimulated cell spreading. (A) NIH3T3 fibroblasts were detached 
from the substratum and held in suspension for 45–60 min, and then 
half of the cells were plated onto FN for 20 min (Adh.:  ) while 
the other half remained in suspension (Adh.:  ). Cell lysates were 
incubated with GST-agarose (lane 1) or GST-Abl-SH2-agarose 
(lanes 2 and 3). After washing the beads stringently, bound proteins 
were subjected to Western blot analysis using pTyr antibodies 
(WB:pTyr). (B) Abl
 / Arg
 /  MEFs stably reconstituted with vector 
(pMSCV, lanes 1 and 2) or c-Abl (lanes 3 and 4) were pretreated 
with 5  M STI571 (lanes 2 and 4) or vehicle (DMSO, lanes 1 and 3) 
for 8 h. Cell lysates were incubated with Abl-SH2 and processed 
as in A. (C and D) Abl[Abl
 / Arg
 / ] MEFs were maintained in 
suspension for 60 min (C) or replated onto FN (D). As indicated, 1  M 
latrunculin A (Lat. A), 1  M STI571, or 0.5  M SU6656 was added 
to culture media before cell detachment (C, lanes 2–4). Cell lysates 
were incubated with Abl-SH2 and processed as described in A. 
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their isolation using Abl-SH2 was increased by both FN and
latrunculin, which activate c-Abl, and decreased by both
STI571 and deletion of Abl/Arg. Thus, we investigated the
identity the 
 
 
 
60-kD pTyr-proteins.
 
The p62 docking protein Dok1 binds Abl-SH2 when
c-Abl is active
 
Because Dok1 (downstream of tyrosine kinases) is a 62-kD
protein that is tyrosine phosphorylated in Bcr-Abl–trans-
formed cells (Wisniewski et al., 1994; Carpino et al., 1997;
Yamanashi and Baltimore, 1997), we checked if Dok1 was a
component of the 
 
 
 
60-kD pTyr-proteins isolated with Abl-
SH2. Using antibodies specific for Dok1 and lysates from la-
trunculin-treated suspended wild-type (WT; Dok1
 
 
 
/
 
 
 
) or
Dok1
 
 
 
/
 
 
 
 MEFs, we found that Abl-SH2 did isolate Dok1
(Fig. 2 A). The level of 
 
 
 
60-kD pTyr-proteins isolated with
Abl-SH2 was significantly decreased using lysates from
Dok1
 
 
 
/
 
 
 
 MEFs compared with Dok1
 
 
 
/
 
 
 
 MEFs (unpub-
lished data), indicating that Dok1 is likely a component of
pTyr-p60. To explore this possibility further, we performed
side-by-side analysis of Abl-SH2 pull downs and Dok1 im-
munoprecipitates (Fig. 2 B). The levels of pTyr on Dok1
correlated with the amount of pTyr-p60 isolated with Abl-
SH2. Direct evidence that Dok1 was a component of the
 
 
 
60-kD pTyr-proteins isolated with Abl-SH2 was obtained
using Dok1 antibodies to immunoprecipitate Dok1 from
proteins that were eluted from Abl-SH2 (Fig. 2 C). We also
found that the pTyr on Dok1 was increased during latrun-
culin treatment and fibroblast spreading, and this increase
was largely blocked by STI571 (Fig. 2 D). These data indi-
cate that Dok1 is a component of the 
 
 
 
60-kD pTyr-pro-
teins isolated with Abl-SH2 and support the conclusion that
Dok1 is a substrate for c-Abl in spreading MEFs.
 
Y361 of Dok1 is phosphorylated by c-Abl in response 
to cell adhesion
 
To identify residues of Dok1 that are phosphorylated by
c-Abl, we stably expressed WT HA-Dok1 and various Y to F
HA-Dok1 point mutants in pMSCV[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] and
Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs. We observed constant low levels
of pTyr on all HA-Dok1 constructs when expressed in
pMSCV[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs (Fig. 3 A; unpublished data).
In the Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs, the pTyr content of HA-
Dok1 was elevated compared with the HA-Dok1 from
pMSCV[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs (Fig. 3 A, lanes 1 and 2). The
Y361F Dok1 and Y295F/Y361F Dok1 mutants had de-
creased pTyr content in Abl[Abl
 
 
 
/
 
 
 
Arg
 
 
 
/
 
 
 
] MEFs spreading
on FN, whereas the pTyr content of the other mutants, in-
cluding Y295F, was similar to that of WT Dok1. This find-
ing suggests that the phosphorylation of Y361 of Dok1 is in-
duced by c-Abl during cell spreading, so we investigated
whether or not c-Abl could directly phosphorylate Y361 of
Dok1. In vitro kinase assays were performed with affinity-
purified c-Abl (Woodring et al., 2001) and bacterially ex-
pressed GST-Dok1 proteins. Tryptic phosphopeptide map-
ping of WT Dok1 phosphorylated by c-Abl in vitro revealed
seven prominent tryptic phosphopeptides, suggesting that
c-Abl can phosphorylate multiple tyrosines in Dok1. The map
of the Y361F Dok1 mutant was missing two of those tryptic
phosphopeptides (Fig. 3 B, 1 and 2). The predicted mobility
of the Dok1 tryptic peptide containing Y361 corresponds to
the peptide labeled “2”. The lysine defining the tryptic
cleavage site upstream of Y361 is embedded in acidic resi-
dues and, therefore, may be poorly cleaved by trypsin. To
determine if peptide 1 was a longer, incompletely digested
tryptic peptide containing pY361, peptide 1 was purified
from the WT Dok1 map and redigested with trypsin. This
procedure yielded some peptide 2 (Fig. 3 C). Peptides corre-
sponding to the long (Fig. 3, 1) and short (Fig. 3, 2) pY361-
Dok1 tryptic peptides were synthesized and found to mi-
grate at the same coordinates on our tryptic maps (Fig. 4 A;
see Materials and methods). These results indicate that c-Abl
can directly phosphorylate Dok1 at Y361 in vitro. Y361 of
Dok1 also appeared to be a target for c-Abl in spreading cells
because replating MEFs on FN increased pTyr on Dok1 but
had little effect on Y361F Dok1 (Fig. 3, A and D).
To further investigate the phosphorylation of Y361 of
Dok1 by c-Abl, we performed two additional sets of experi-
ments: phosphopeptide mapping of cellular Dok1 and im-
munoblotting using a pY361 phosphospecific Dok1 anti-
body (Fig. 4). For tryptic phosphopeptide mapping, HA-
Figure 2. Dok1 is tyrosine phosphorylated when Abl is active in 
cells. MEFs were pretreated with STI571 and latrunculin A as indicated 
(see Materials and methods), and then detached and either held in 
suspension (Adh.:  ) or replated onto FN for 20 min (Adh.:  ). 
(A) Lysates from latrunculin-treated passage 3 MEFs null for Dok1 
(Dok1
 / ) or littermate control MEFs (Dok1
 / ) were incubated with 
Abl-SH2, and the bound Dok1 was detected using Dok1 antibodies 
in Western blot analysis. Lane 1 contained whole cell lysate as a 
positional control. (B) Dok1 was immunoprecipitated ( 6043) from 
the same suspended cell lysates (lanes 1–3) as used for the Abl-SH2 
affinity analysis (lanes 4–6). Precipitated proteins were subjected to 
Western blot analysis using pTyr antibodies. Note that the slight 
variation in mobility of p62 between the immunoprecipitates and 
the Abl-SH2 pull downs is likely due to the presence of a large 
quantity of Abl-SH2 domain in lanes 4–6. (C) Abl-SH2 was incubated 
with the indicated cell lysates, and the bound pTyr-containing 
proteins were eluted from the agarose with 0.5 M phenylphosphate. 
Eluates were diluted and subjected to immunoprecipitation with 
Dok1 antibodies. Equal fractions from the supernatant (lanes 5–7) 
and pellet (lanes 2–4) of the Dok1 immunoprecipitate were subjected 
to Western blot analysis using pTyr antibodies. Lane 1 contained a 
Dok1 immunoprecipitate from latrunculin-treated cells. (D) Dok1 was 
immunoprecipitated from lysates of the indicated Abl[Abl
 / Arg
 / ] 
MEFs, and then subjected to sequential Western blot analysis using 
pTyr antibodies, followed by Dok1 antibodies. 
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Dok1 was immunoprecipitated from 
 
32
 
P-labeled 293T cells
coexpressing c-Abl (Fig. 4 A, left; technical obstacles prohib-
ited us from 
 
32
 
P labeling spreading MEFs). Two 
 
32
 
P-labeled
tryptic peptides generated from Dok1 comigrated with the
synthetic pY361 synthetic peptides (Fig. 4 A, arrows). These
tryptic phosphopeptides were absent in maps of Y361F
Dok1 (Fig. 3 B), implying that WT Dok1 is phosphorylated
at Y361 in cells. Using phosphoamino acid analysis, we de-
tected enhanced pTyr levels on 
 
32
 
P-WT Dok1 relative to
that of 
 
32
 
P-Y361F Dok1 when each was immunoprecipi-
tated from cells coexpressing c-Abl (Fig. 4 B). A phospho-
specific antibody directed against pY361 of Dok1 ( pY361)
was also used to examine the pY361 content of Dok1 in cells
(Fig. 4 C). A prominent signal was detected using  pY361
Figure 3. Expression of c-Abl increases the pTyr on Dok1 but 
not Y361F Dok1. (A) HA-Dok1 mutants were expressed stably in 
Abl
 / Arg
 /  MEFs previously reconstituted with either pMSCV 
empty vector (lane 1) or c-Abl (lanes 2–7). The mutated tyrosines 
(Y to F) in HA-Dok1 are indicated at the top of each lane. HA-Dok1 
mutants were immunoprecipitated from cell lysates of spreading 
cells and subjected to sequential Western blot analysis using pTyr 
antibodies, and then Dok1 antibodies. (B) Tryptic phosphopeptide 
maps of GST-Dok1 and GST-Y361F Dok1. Purified GST-Dok1 
proteins were phosphorylated using  -[
32P]ATP and purified c-Abl. 
GST-Dok1 was isolated with glutathione-Sepharose and subjected 
to SDS-PAGE. The 
32P-labeled Dok1 band was excised from the gel 
and processed for tryptic phosphopeptide mapping (see Materials 
and methods). The sample origin is located at the lower left. Circles 
drawn on the right panel indicate where peptides 1 and 2 would have 
run if they were present in the map of Y361F Dok1. (C) Peptide 1 
was purified from the TLC plate of WT 
32P-Dok1 shown in B. The 
map of purified peptide 1 incubated in buffer without trypsin (top) 
and the map of purified peptide 1 redigested with trypsin (bottom) 
are shown. (D) The indicated Abl[Abl
 / Arg
 / ] MEFs described in 
A were held in suspension for 45–60 min, and then half of the cells 
were plated onto FN for 20 min (lanes 2 and 4), while the other half 
remained in suspension (lanes 1 and 3). HA-Dok1 constructs were 
immunoprecipitated from cell lysates and subjected to sequential 
Western blot analysis using pTyr antibodies, and then Dok1 antibodies.
Figure 4. c-Abl increases the phosphorylation of Y361 of Dok1 in 
cells. (A) Tryptic phosphopeptide map of HA-Dok1 from 
32P-labeled 
HEK293T cells that were coexpressing c-Abl. HA-Dok1 was immu-
noprecipitated and processed for tryptic phosphopeptide mapping. 
Before spotting onto the TLC plate, trypsin-digested synthetic pY361 
Dok1 peptides (see Materials and methods) were added to the 
32P-Dok1 sample.  Arrows indicate the position of synthetic pY361 
Dok1 peptides detected by ninhydrin staining.  The autoradiogram 
(left) was obtained by exposing the ninhydrin-stained TLC plate 
(right) to film. The mobility of the synthetic pY361 Dok1 peptides 
corresponds to that of the phosphopeptides labeled “1” and “2” 
derived from 
32P-Dok1 in Fig. 3 B. (B) Phosphoamino acid analysis 
of WT Dok1 and Y361F Dok1 from 
32P-labeled HEK293T cells that 
were coexpressing c-Abl. Samples were prepared as described 
previously (Meisenhelder et al., 1999). Right panel shows ninhydrin 
staining indicating the position of the phosphoamino acid standards 
that were added to the 
32P samples. (C) Dok1 was immunoprecipi-
tated from lysates of the indicated cells, and then subjected to Western 
blot analysis using the antibodies indicated at the far right of each 
row of panels. (left) HA-Dok1 was immunoprecipitated from lysates 
of HEK293T cells that were transfected with empty vector (lane 1); 
KD Abl and WT Dok1 (lane 2); WT c-Abl and WT Dok1 (lane 3); or 
WT c-Abl and Y361F Dok1 (lane 4). (bottom left) pY361-Dok1 
synthetic peptide 1 was added to the to the  pY361Dok1 immuno-
blotting solution. (middle) HA-Dok1 was immunoprecipitated from 
lysates of Abl[Abl
 / Arg
 / ] MEFs expressing either WT Dok1 (lanes 
1–3) or Y361F Dok1 (lane 4). MEFs were held in suspension (lane 1), 
replated on FN (lanes 2 and 4), or pretreated with STI571 and 
replated on FN (lane 3). (right) Endogenous Dok1 was immunopre-
cipitated ( 6043) from the following spreading MEFs: lane 1, Dok1
 / ; 
lane 2, Abl[Abl
 / Arg
 / ]; or lane 3, pMSCV[Abl
 / Arg
 / ]. Because 
endogenous Dok1 migrates close to the IgG heavy chain, Dok1
 /  
MEFs were used as a control (lane 1). Note that the intensity level of 
signals between the left, middle, and right panels are not directly 
comparable because these results are from three separate experiments.Abl phosphorylates Tyr361 of Dok1 | Woodring et al. 497
in immunoblot analysis of Dok1 immunoprecipitated from
HEK cells coexpressing Dok1 and c-Abl (Fig. 4 C, top left,
lane 3). Addition of the synthetic pY361 Dok1 peptide to
the   pY361 immunoblotting solution effectively reduced
this signal (Fig. 4 C, bottom left). The signal was signifi-
cantly less for Dok1 immunoprecipitated from cells coex-
pressing either WT Dok1 and kinase-deficient (KD) Abl or
Y361F Dok1 and WT c-Abl (Fig. 4 C, left). Thus, c-Abl is
capable of phosphorylating Y361 of Dok1 both in vitro and
in cells.
Results obtained with the Y361F Dok1 mutant suggested
that Y361 is phosphorylated by c-Abl in MEFs spreading on
FN (Fig. 3, A and D). Using the  pY361 Dok1 antibody, we
found that FN stimulation increased the pY361 content of
Dok1 relative to that of Dok1 from suspended cells (Fig. 4
C, middle). STI571 largely blocked the stimulatory effect
of FN, and pY361 was not detected on Y361F Dok1. We
also detected pY361 on endogenous Dok1 from spreading
Abl[Abl
 / Arg
 / ] MEFs, whereas very little pY361 was de-
tected on Dok1 from pMSCV[Abl
 / Arg
 / ] MEFs, and no
signal was detected in an immunoprecipitate from Dok1
 / 
cells, as expected (Fig. 4 C, right). Based on the results shown
in Figs. 3 and 4, we conclude that c-Abl induces phosphory-
lation of Dok1 at Y361 in MEFs spreading on FN.
Tyrosine phosphorylation of Dok1 at Y361 coincides 
with F-actin microspike formation
c-Abl activity prolongs the persistence of exploratory filopo-
dia and F-actin microspikes during the early stages of cell
spreading (Woodring et al., 2002). In addition, deletion of
four amino acids at the extreme COOH terminus generates
a form of Abl (c-Abl*) that remains active in suspended cells
(Woodring et al., 2001). Consistent with these two observa-
tions, suspended Abl
 /  cells expressing WT c-Abl con-
tained few to no microspikes (Fig. 5 A, top) and basal c-Abl
activity, whereas suspended cells expressing c-Abl* contained
numerous F-actin microspikes (Fig. 5 A, bottom). To ex-
plore Abl substrates involved in c-Abl–induced microspike
formation in suspended cells, we used Abl-SH2 to isolate
Abl substrates from each of these cell lines (Fig. 5 B). After
FN stimulation, Abl-SH2 isolated similar amounts of pTyr-
containing proteins from the lysates of c-Abl– and c-Abl*–
expressing cells (Fig. 5 B, lanes 1 and 3). In suspended cells,
Abl-SH2 isolated more pTyr-p62 from lysates of cells ex-
pressing c-Abl* than from lysates of cells expressing WT
c-Abl (Fig. 5 B, lanes 2 and 4). Thus, there was an increase
in F-actin microspikes in detached cells expressing active Abl
and a corresponding increase in the quantity of pTyr-p62
(Dok1) isolated using Abl-SH2.
We examined if Dok1 could enhance the c-Abl–induced
increase in the number of filopodia in spreading MEFs. Sta-
Figure 5. Stable expression of activated c-Abl (c-Abl*) in nonad-
herent fibroblasts increases the pTyr content on Dok1 pulled down 
with Abl-SH2. (A) c-Abl or activated c-Abl* (c-Abl missing the last 
four amino acids; Woodring et al., 2002) was stably expressed in 
Abl
 /  MEFs. The deconvolution microscopy images shown high-
light the differences observed in cells that were fixed after 60 min in 
suspension (Woodring et al., 2002). The F-actin cytoskeleton was 
stained using TRITC-phalloidin. (B) Cell lysates from FN-replated 
(lanes 1 and 3) and suspended (lanes 2 and 4) MEFs were incubated 
with Abl-SH2, and the bound proteins were subjected to Western 
blot analysis using pTyr antibodies. Arrow indicates the p62 kD 
band we identified as Dok1 (Fig. 2).
Figure 6. Dok1 expression increases Abl-dependent filopodia 
during cell spreading, whereas Y361F Dok1 expression does not 
affect filopodia. (A) The indicated Abl
 / Arg
 /  MEF lines were held 
in suspension for 45–60 min, and then replated onto FN-coated 
coverslips for 20 min before fixation. Fixed cells were stained with 
TRITC-phalloidin, and images were obtained using deconvolution 
microscopy. Images shown highlight the differences between the 
populations of cells. (B) The number of F-actin microspikes/filopodia 
were counted on 200–1,000 randomly selected cells from each 
indicated cell line as described in Materials and methods. Error bars 
represent SEM; *, P   0.001 compared with the parent cell line not 
expressing Dok1.498 The Journal of Cell Biology | Volume 165, Number 4, 2004
ble expression of WT Dok1 (3–5-fold endogenous levels) in
Abl[Abl
 / Arg
 / ] MEFs increased the number of filopodia
present at the cell surface (Fig. 6). This increase was depen-
dent on the presence of c-Abl because Dok1 expression did
not enhance membrane protrusions in pMSCV[Abl
 / Arg
 / ]
MEFs (Fig. 6, A and B). The stable expression of Dok1
together with c-Abl in Abl
 / Arg
 /  cells caused a 1.4–2.2-
fold increase (P   0.001) in the number of F-actin–rich
membrane protrusions over the number observed with c-Abl
expression alone (Fig. 6 B). Like WT Dok1, Y450F Dok1
also increased the number of filopodia in spreading Abl-
reconstituted cells. In contrast, expression of Y361F or
Y361F/Y295F Dok1 did not increase the number of filopo-
dia induced by c-Abl during cell spreading (Fig. 6 B).
We also investigated whether or not Dok1 is required for
filopodia formation in spreading cells using early passage
primary MEFs null for Dok1 (Fig. 7, A and B). Compared
with MEFs of the same passage number from littermate con-
trols, the MEFs lacking Dok1 exhibited 2.1–3.2-fold fewer
filopodia during spreading on FN. The number of filopodia
on Dok1
 /  MEFs was similar to that found on Abl
 / 
Arg
 /  MEFs (Fig. 7 B). c-Abl expression did not increase
F-actin microspikes on Dok1
 /  MEFs, and STI571 treat-
ment decreased the number of filopodia on WT MEFs but
not on Dok1
 /  MEFs (Fig. 7 C). In summary, c-Abl ex-
pression was required for Dok1 to enhance filopodia forma-
tion (Fig. 6), and Dok1 was required to observe effects of
c-Abl on filopodia during cell spreading (Fig. 7 C). These
data implicate Dok1 as a mediator for c-Abl in the forma-
tion or maintenance of filopodia during cell spreading. Be-
cause c-Abl and Dok1 are required for one another’s effects,
they most likely are components of the same signaling path-
way in modulating filopodia.
Dok1 and Abl are localized to filopodia
in spreading fibroblasts
Because spatial organization of intracellular signaling pro-
teins is of critical importance for achieving the proper bio-
logical output of a signaling pathway, we examined the lo-
calization of Dok1 and c-Abl during cell spreading. Dok1
was localized in filopodia of spreading MEFs as well as, more
generally, at the plasma membrane (Fig. 8 A). These obser-
vations are consistent with the presence of an NH2-terminal
pleckstrin homology (PH) domain of Dok1, which may
promote its association with phosphoinositides in the
plasma membrane (Zhao et al., 2001). Higher magnification
of individual filopodia (Fig. 8 B, top) revealed that Dok1
was present along and at the tips of filopodia. This spatial
analysis suggests that Dok1 is most likely acting locally at
the cell perimeter to affect filopodia. Similar staining of
filopodia was observed using pTyr antibodies and Abl anti-
bodies (Fig. 8 B, middle). Furthermore, Abl and Dok1 were
detected in the same filopodia (Fig. 8 B, bottom). The local-
ization of both c-Abl and Dok1 in filopodia is consistent
with Dok1 acting as a local substrate for c-Abl in modulat-
ing filopodia protrusion.
Staining of suspended MEFs expressing c-Abl* with pTyr
antibodies revealed discrete brilliant staining at the tips of
peripheral actin microspikes (Fig. 8 C). Pretreatment with
STI571 eliminated the microspikes and therefore eliminated
the pTyr staining at the tips of the microspikes. Dok1 was
localized to the tips of peripheral F-actin microspikes in sus-
pended cells expressing c-Abl* (Fig. 8 C, right), suggesting a
role for Dok1 in formation of these F-actin structures.
Phosphorylation of Y361 can promote Dok1 binding to
the SH2 domains of p120RasGAP (p120) and the Nck
adaptor protein (Tang et al., 1997; Murakami et al., 2002;
Shah and Shokat, 2002). Whereas association with Nck in-
volves the phosphorylation of Y361 of Dok1, association
with p120 appears to involve phosphorylation of five addi-
tional tyrosines (Murakami et al., 2002). We did not detect
an association between p120 and Dok1 in lysates of spread-
ing MEFs, nor did we detect any change in the pTyr content
of p190RhoGAP, which associates with p120 (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200312171/
DC1). In contrast, we did detect endogenous Nck in im-
munoprecipitates of Dok1 using lysates from spreading
Abl[Abl
 / Arg
 / ] MEFs (Fig. 9 A, right). WT Dok1 was
present in Nck immunoprecipitates, whereas Y361F Dok1
was not (Fig. 9 A, left). Correspondingly, the Dok1 that
coimmunoprecipitated with Nck was phosphorylated at
Y361 (Fig. 9 A). Coimmunoprecipitation of endogenous
Dok1 and Nck was detected in spreading MEFs (Fig. 9 B,
Figure 7. Dok1
 /  primary MEFs have fewer filopodia. Spreading 
passage 3 Dok1
 /  MEFs (bottom row, middle and right) and the 
littermate Dok1
 /  MEFs (top row, middle and right) were analyzed 
side-by-side with spreading Abl[Abl
 / Arg
 / ] and pMSCV[Abl
 /  
Arg
 / ] MEFs (left panels, top and bottom, respectively). TRITC-
phalloidin staining (A), and quantification of the number of F-actin 
microspikes/filopodia in spreading cells and statistics (B and C) 
were performed as described in Fig. 6. Error bars represent SEM; *, 
P   0.001 when the values (represented by the columns) on either 
side of the horizontal line are compared. (C) As indicated, MEFs 
were pretreated with STI571 or were stably infected with c-Abl or 
control (pMSCV) retrovirus and selected for 4 d. Note that data 
for the histograms was normalized to WT MEFs (set to 1) so that 
experiments performed on separate occasions could be compared.Abl phosphorylates Tyr361 of Dok1 | Woodring et al. 499
lanes 6 and 7), and this association was enhanced in cell lines
stably expressing elevated levels of Dok1 (Fig. 9 B, lanes 4
and 5; note that lanes 7 and 8 were exposed to film longer
than lanes 4–6). In addition, the interaction between the
Dok1 and Nck was reduced in STI571-treated spreading
MEFs (Fig. 9 B, lane 8) and in suspended MEFs (Fig. 9 B,
lane 9). Together these data strongly imply that the associa-
tion between Dok1 and Nck is stimulated by c-Abl.
To investigate if Nck is involved in filopodia formation
during cell spreading, we used Nck1
 / Nck2
 /  MEFs
(Gruenheid et al., 2001). The number of filopodia in
spreading Nck1
 / Nck2
 /  MEFs was reduced by threefold
relative to cells stably reconstituted with endogenous levels
of Nck1 (Fig. 9 C). The number of filopodia observed in
MEFs reexpressing Nck1 was reduced with STI571 treat-
ment (Fig. 9 D); however, STI571 did not affect the filopo-
dia of Nck1
 / Nck2
 /  MEFs, suggesting that Nck is in-
volved in Abl-mediated filopodia formation.
Results from cotransfection experiments suggest that Nck1,
Dok1, and Abl may form a ternary complex in cells (Fig. S2,
available at http://www.jcb.org/cgi/content/full/jcb.200312171/
DC1). The association of all three proteins was significantly de-
creased when Y361F Dok1 was used instead of WT Dok1, when
KD Abl was used instead of WT Abl, or when cells were treated
with STI571. Thus, a signaling complex containing Abl, Dok1,
and Nck may form in cells, and its formation is dependent on
Abl activity and phosphorylation of Y361 of Dok1. In summary,
our data suggest that c-Abl transduces signals to actin at the cell
periphery by phosphorylating Y361 of Dok1 and recruiting Nck.
Discussion
We propose a novel c-Abl signaling pathway that promotes
formation of filopodial exploratory structures during cell
spreading. This pathway involves (a) the activation of c-Abl
on integrin interaction with FN, (b) the Abl-dependent
phosphorylation of Y361 of Dok1, and (c) the recruitment
of the Nck adaptor protein to pY361-Dok1. Our model is
consistent with two recent reports demonstrating that clus-
tering of Nck at the cell membrane initiates localized actin
polymerization (Campellone et al., 2004; Rivera et al.,
2004). Nck can associate with and/or affect proteins that
promote assembly of F-actin, such as N-WASP (Rivero-Lez-
cano et al., 1995; Rohatgi et al., 2001; Benesch et al., 2002),
WAVE-1 (Eden et al., 2002), and PAK (p21-activated pro-
tein kinase; Zhao et al., 2000). Nck may also directly associ-
ate with c-Abl via its NH2-terminal SH3 domains (Ren et
al., 1994). Activation of some of these Nck binding pro-
teins, such as PAK1 and WAVE-1, appears to require the
Cdc42 GTPase. Because we did not observe reduction of
Abl-induced filopodia formation on expression of domi-
nant-negative Cdc42 (Woodring et al., 2002), we propose
that the effect of c-Abl on filopodia is Cdc42 independent.
Notably, Nck can increase N-WASP–stimulated actin poly-
merization in the absence of Cdc42 in vitro (Moreau et al.,
2000; Rohatgi et al., 2001; Benesch et al., 2002). Likewise,
high concentrations of Nck at the cell membrane stimulates
localized actin polymerization through a mechanism that
does not require Cdc42 or WAVE-1 but does involve
N-WASP (Rivera et al., 2004). Our preliminary studies sug-
Figure 8. Dok1, pTyr, and c-Abl localize 
to the tips of filopodia and peripheral 
actin microspikes. (A) Passage 5 Dok1
 /  
MEFs were infected with pBABE-puro 
vector (left) or Dok1 retrovirus (right), 
and then selected for 4 d. MEFs were 
fixed during spreading on FN (20 min) 
and stained. FITC-phalloidin was used to 
detect F-actin (green); Dok1 (A3)   Texas 
red goat– mouse antibodies were used 
to detect Dok1 (red); and Hoechst 33258 
(blue) was used to detect nuclei. (B) 
Spreading MEFs were stained with FITC-
phalloidin and the following antibodies: 
Dok1 (A3, first row), pTyr (4G10, second 
row), or c-Abl (8E9, third row). Texas red 
goat– mouse antibodies were used as 
secondary antibodies. Abl, Dok costaining 
(fourth row) was performed sequentially, 
first staining with  Dok (A3)   goat 
 mouse-Alexa Fluor 488, then with  Abl 
(8E9, mouse mAb) directly conjugated to 
Alexa Fluor 546. All panels show images 
of filopodia protruding from MEFs spread-
ing on FN. The top left panel is a higher 
magnification of the circled area in A. 
(C, left and middle) FITC-phalloidin and 
 pTyr staining of suspended cells stably 
expressing c-Abl*, which remains active 
in suspended cells. Cells were pretreated 
with STI571 as indicated. (right) FITC-
phalloidin and  Dok1 (A3) staining of a 
suspended cell stably expressing c-Abl*.500 The Journal of Cell Biology | Volume 165, Number 4, 2004
gest that N-WASP may be involved in Abl-mediated filopo-
dia formation (unpublished data), whereas PAK1 does not ap-
pear to be involved (Fig. S3, available at http://www.jcb.org/
cgi/content/full/jcb.200312171/DC1). Our results establish
that Nck is critical for Abl/Dok1-mediated filopodia forma-
tion in spreading MEFs, but the details of the signaling
pathway downstream of Nck await further investigation.
Several publications support a role for Abl kinases in reg-
ulation of F-actin polymerization in cells (for review see
Lanier and Gertler, 2000; Woodring et al., 2003; Hernan-
dez et al., 2004). Overall, it appears that c-Abl stimulates
filopodia formation, membrane ruffling, and neurite ex-
tension, but inhibits chemotaxis (Frasca et al., 2001; Kain
and Klemke, 2001). At first glance, this finding may ap-
pear as a paradox: how can c-Abl increase actin polymeriza-
tion yet inhibit cell movement? This enigma might be re-
solved by considering the function of filopodia. Filopodia
(and membrane ruffles) are present on cells that have
paused to explore their environment (Machesky 2000). If a
cell remains in the exploratory phase for an extended time,
directed migration may progress slower. We (and others)
have found that primary cultured Abl-null cells spread
faster than the Abl-reconstituted or WT cells (Sheetz, M.,
personal communication; unpublished data). Thus, c-Abl
may slow migration or spreading by promoting formation
of actin structures that permit a cell to pause and explore
the surroundings before moving toward a target.
Based on overexpression studies, it has been suggested that
Dok1 and Dok2 regulate cell motility (Noguchi et al., 1999;
Hosooka et al., 2001; Master et al., 2001). Dok1 may also
affect plasma membrane ruffling because GFP-Dok1 under-
goes a PH domain–dependent translocation to the plasma
membrane in response to PDGF (Zhao et al., 2001) and is
found in the cytoskeletal and membrane fractions of cells
(Noguchi et al., 1999; Hosooka et al., 2001; Zhao et al.,
2001). The PH domain of Dok1 is required for tyrosine
phosphorylation of Dok1 (Zhao et al., 2001), suggesting
that the tyrosine kinases that phosphorylate Dok1 localize at
or near the plasma membrane. These observations are con-
sistent with Dok1 regulating localized F-actin–mediated
processes.
There are five Dok family members (Dok1–Dok5). We
detected expression of Dok1 and Dok2 in the MEFs used
in this paper (unpublished data). The COOH-terminal
YXXP Abl consensus phosphorylation sites are not con-
served in Dok3, Dok4, or Dok5, and these proteins appear
to have functions distinct from Dok1 and Dok2 (Cong et
al., 1999; Grimm et al., 2001). Recently, it was reported
that pTyr-Dok2 can increase Abl kinase activity when co-
expressed with c-Abl in HEK293T cells, presumably by
binding to and displacing both the SH2 and SH3 domains
of c-Abl (Master et al., 2003). This finding raises the inter-
esting possibility that phosphorylation of Dok2 might am-
plify the effect of c-Abl; however, we did not detect pTyr
on Dok2 immunoprecipitated from MEFs plated on FN
(unpublished data), so it is unlikely that Dok2 activates
c-Abl or mediates the effects of c-Abl in FN-stimulated
MEFs. In our analysis, we found that, similar to the over-
expression of other adaptor or docking proteins (e.g., Nck,
Crk, Abi, and Dok2), Dok1 also increased the pTyr con-
tent of c-Abl when coexpressed in HEK293T cells (Wood-
ring et al., 2003; unpublished data). This effect was not
dependent on Y361 phosphorylation because the Y361F
and Y295F/Y361F Dok1 mutants also increased the pTyr
content of c-Abl to a similar level as WT Dok1. This find-
Figure 9. The Nck adaptor protein is involved in Abl-dependent 
filopodia formation. (A and B) Abl
 / Arg
 /  MEFs were stably 
infected with pMSCV empty vector, c-Abl, WT Dok1, and/or Y361F 
Dok1 retrovirus as indicated. MEFs were held in suspension for 
60 min, and then lysed (B, lane 9) or replated onto FN for 25 min 
(all other lanes in A and B). (A) Endogenous Nck and Dok1 were 
immunoprecipitated with  5547 (lanes 1–3) and  12CA5 (lanes 4 
and 5), respectively. Western blot analysis was performed using 
antibodies indicated at the right. (B) Lanes 1–3 contain whole cell 
lysates, and lanes 4–10 contain Nck immunoprecipitates from lysates 
of Abl[Abl
 / Arg
 / ] MEFs expressing endogenous Dok1 (lanes 3 
and 6–8) or increased levels of Dok1 (lanes 1, 2, 4, 5, 9, and 10). As 
indicated, MEFs were pretreated with DMSO (lane 7) or 5  M STI571 
(lane 8). Exposure time for lanes 7 and 8 was  10 times longer than 
for lanes 4–6. (C and D) MEFs null for Nck1 and Nck2 were stably 
reconstituted with empty vector (left) or Nck1 (right). Cells were 
plated on FN for 25 min, fixed, and stained with TRITC-phalloidin. 
The number of F-actin microspikes and filopodia were counted as 
described in Materials and methods. *, P   0.001 compared with 
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ing suggests that Dok1 may activate c-Abl through an in-
termediate protein or by a binding mechanism that does
not require Y361 of Dok1 in HEK293T cells. Although
these overexpression studies are interesting, the results ob-
tained may not be applicable to all systems. For example,
the endogenous c-Abl was still activated during FN cell
spreading in Dok1
 /  MEFs (unpublished data). For these
reasons, we believe that neither Dok2 nor activation of
c-Abl by Dok1 is responsible for the effect of c-Abl on
filopodia in spreading MEFs.
Dok1 has several I/LYXXP consensus sites, including
LY295AEP, LY314SDP, IY361DEP, and LY376DLP. Although
c-Abl can phosphorylate several tyrosine residues of Dok1 in
vitro (Fig. 3 B), it appears that c-Abl predominantly phos-
phorylates Y361 in spreading MEFs. Y361 of Dok1 is also
a substrate for Src in v-Src transformed cells (Shah and
Shokat, 2002) and in CHO cells overexpressing the insulin
receptor (Noguchi et al., 1999). Src may contribute to the
pTyr of Dok1 in MEFs because some Dok1 pTyr remains
when cells are treated with STI571 (Fig. 2 D). Src and Abl
may even act cooperatively to stimulate pTyr-Dok1, as has
been suggested previously in MEFs stimulated with PDGF
(Plattner et al., 1999).
The pTyr-Dok1 isolated from spreading cells associated
with purified Abl-SH2 domain (Fig. 1 B). The binding of
Abl substrates to the Abl-SH2 domain can promote proces-
sive phosphorylation of Abl substrates (Duyster et al., 1995;
Mayer et al., 1995). It is possible that the tyrosine phosphor-
ylation of Dok1 may allow Dok1 to stably associate with the
Abl-SH2 domain to promote further tyrosine phosphoryla-
tion of Dok1. Because Dok1 can oligomerize through its
pTyr binding domain (Songyang et al., 2001), c-Abl could
also promote phosphorylation of Y361 of other Dok1 mole-
cules in an oligomer. However, although Abl-SH2 did bind
Dok1 from spreading MEFs, we were unable to detect coim-
munoprecipitation of the endogenous proteins, suggesting
that their association is transient and/or that minor popula-
tions of Dok1 and c-Abl associate, perhaps those molecules
localized in filopodia.
Dok1 appears to be a multifunctional signaling protein
with reported roles in cell growth, transformation, axonal
guidance, and immune response (Holland et al., 1997; Ya-
manashi et al., 2000; Di Cristofano et al., 2001; Songyang
et al., 2001; Zhao et al., 2001; Murakami et al., 2002).
We have uncovered a new function of Dok1 in regulating
F-actin microspikes and filopodia during fibroblast spread-
ing. Notably, instead of using overexpression and dominant-
negative approaches, which most other investigators have
used to study Abl or Dok, we have used a genetic strategy
with cells from knockout mice reexpressing levels of protein
that are comparable to endogenous levels. We have defined a
novel signaling pathway downstream of c-Abl leading to
F-actin assembly and filopodia formation. Precisely localized
c-Abl signaling at the tips of filopodia may be important for
regulating the localized dynamics of filopodia extension, re-
traction, or attachment to the ECM to mediate the explor-
atory process. Further studies are required to determine if
c-Abl, pY361Dok1, and Nck can fine-tune cell guidance by
modulating cell exploration in vivo during embryonic devel-
opment, axon path finding, or wound healing.
Materials and methods
cDNA expression using retroviral-mediated gene transfer
Stable Abl
 / Arg
 /  polyclonal cell lines reconstituted with murine type IV
c-Abl were generated using retroviral-mediated gene transfer and the
pMSCV-hyg retroviral vectors (Pear et al., 1993). Stable polyclonal MEF
lines (pMSCV[Abl
 / Arg
 / ] and Abl[Abl
 / Arg
 / ]) were established using
hygromycin selection (Woodring et al., 2002). Murine Dok1 and Dok1
mutant cDNAs were stably expressed by retroviral-mediated gene transfer
using the pBABE-puro retroviral vectors and puromycin for selection. Us-
ing retrovirus (without helper virus) for stable expression of proteins re-
sulted in levels of protein from one- to fivefold endogenous levels. Nck1
reexpressing Nck1
 / Nck2
 /  MEFs were generated in Tony Pawson’s lab-
oratory using retroviral-mediated gene transfer (Gruenheid et al., 2001).
Antibodies
pTyr (4G10) and Myc (9E10) mAbs were purchased from Upstate Biotech-
nology; Dok1 mAb (A3) was purchased from Santa Cruz Biotechnology,
Inc.; HA mAb (12CA5) was purchased from Babco; Flag mAb was ob-
tained from Sigma-Aldrich; and Abl mAb (Ab3) was obtained from Onco-
gene Sciences.  Abl mAb (8E9) was a gift from J.Y.J. Wang. Nck (5547) and
Dok1 (6043) rabbit antibodies were generated by J. Meisenhelder and N.
Carter (The Salk Institute, La Jolla, CA) using GST-Nck1 and GST-Dok1 as
immunogens.   5547 immunoprecipitates Nck1/2 but recognizes only
Nck1 on immunoblots. Affinity-purified pY361Dok1 rabbit polyclonal an-
tibodies were a gift from M. Lakkis (Biosource International, Hopkinton,
MA), and pY412-Abl rabbit polyclonal antibodies were purchased from
Biosource International. Secondary HRP-conjugated antibodies used for
ECL were obtained from Amersham Biosciences. Secondary antibodies
(Texas red, FITC, or Alexa Fluor 488 conjugates) used for immunofluores-
cence were obtained from Southern Biotechnology Associates, Inc. or Mo-
lecular Probes.
Cell culture
The immortal Abl/Arg-deficient fibroblast cell line Abl
 / Arg
 /  was gener-
ated from E9 mouse embryos by A. Koleske (Yale University, New Haven,
CT). The Dok1
 /  primary MEFs (Di Cristofano et al., 2001) and the Nck1
 / 
Nck2
 /  MEFs (Gruenheid et al., 2001) were gifts from P.P. Pandolfi and
T. Pawson, respectively. Cells were maintained in high glucose DME sup-
plemented with 10% FBS (Gemini Bioproducts), L-glutamine, and antibiot-
ics. Early passage MEFs were critical in obtaining the results reported here
because MEFs were altered when grown in culture for longer than 4–8 wk.
Latrunculin A (Molecular Probes) was added to serum-free media at a con-
centration of 1  M for a 2-h pretreatment before cell detachment. Cells
were held in suspension in the same media for an additional 40–60 min.
The Abl inhibitor STI571 (Gleevec™; Novartis) was added to growth me-
dia at a concentration of 1–5  M, and the Src inhibitor SU6656 (Sugen)
was used at a concentration of 0.5–1  M for 1–8 h. The latrunculin and ki-
nase inhibitors were also present in the media throughout the suspension
and reattachment period. Control cells were incubated with DMSO, the
vehicle for inhibitors.
Biochemistry
Fibroblast experiments involving cell detachment, FN stimulation, and im-
munoprecipitation were performed as described previously (Woodring et
al., 2001) using 1% Triton X-100 lysis buffer and brief sonication to pre-
pare cellular lysates. GST-Abl-SH2 experiments were performed in the
presence of 0.5 M NaCl to reduce nonspecific binding. Purified GST or
GST-Abl-SH2 protein was cross-linked to glutathione-Sepharose using
dimethyl-pimelimidate ( 50  g of protein coupled to 10  l of beads per
pull down). 200  g of cell lysate protein were used for pull downs or im-
munoprecipitation, while 2–3 mg of protein were used for coimmunopre-
cipitation experiments.
PAK1 kinase assays were performed as described previously (Zhou et
al., 2003). For in vitro Abl kinase assays, c-Abl was purified via FLAG anti-
body chromatography (Woodring et al., 2001) and used to phosphorylate
GST-Dok1 protein in vitro. GST-Dok1 was isolated with glutathione-Seph-
arose before SDS-PAGE, and the 
32P-labeled Dok1 was processed for phos-
photryptic analysis (Shah and Shokat, 2002).
For in vivo phosphotryptic peptide mapping, Dok1 was coexpressed
with c-Abl in HEK293T cells. After transfection, cells were labeled with 1
mCi/ml 
32P-orthophosphate overnight, and then lysed in RIPA buffer. Dok1
was immunoprecipitated ( HA) and processed for phosphotryptic peptide
mapping and phosphoamino acid analysis as described previously
(Meisenhelder et al., 1999). Tryptic phosphopeptides were separated on
thin layer cellulose (TLC) plates (EM Science) by electrophoresis (pH 1.9,502 The Journal of Cell Biology | Volume 165, Number 4, 2004
1.5 kV, 35 min) and ascending chromatography (phosphochromo buffer,
18 h). Synthetic peptides corresponding to the tryptic peptides containing
mouse Dok1 pTyr361 were synthesized on an ABI 432A Synergy peptide
synthesizer: (LTDSKEDPIpYDEPEGLAPAPPRGLY (peptide 1   GLY) and
EDPIpYDEPEGLAPAPPRGLY (peptide 2   GLY). When digested with 1–10
 g TPCK trypsin these peptides yielded peptides 1 and 2 (underlined).
Very little peptide 2 was generated from in vitro digestion of synthetic pep-
tide 1. When mixed together and added to the 
32P-Dok1 phosphotryptic
samples, the purified synthetic peptides were found to comigrate with the
two pTyr361 spots in maps of Dok1 isolated from 
32P-labeled cells.
Immunofluorescence staining
Cells were prepared as indicated, fixed in suspension, or plated onto cov-
erslips coated with 10  g/ml purified human FN (Calbiochem) for 20–35
min at 37 C as described previously (Woodring et al., 2002). For Abl/Dok
costaining experiments,  Abl (mouse mAb 8E9) was directly labeled with
Alexa Fluor 546 according to kit instructions (Molecular Probes). Fluores-
cent reagents and antibodies are indicated in the figure legends. Wide-
field microscopy was performed using the 60  objective (Olympus). Ap-
plied Precision software (DeltaVision) was used to deconvolve z-section
series of images. For quantification of filopodia and peripheral actin mi-
crospikes during cell spreading, we counted the number of filopodia and
microspikes present on cells visualized with phalloidin, including all visi-
ble protruding microspikes  1   m. Random fields of cells (n    200–
1,000) were selected on coverslips using Applied Precision software. Sta-
tistical analysis of the data was performed using Microsoft Excel software.
Online supplemental material
Three supplemental figures address the mechanism by which pY361-Dok1
induces filopodia during cell spreading. Data in Figs. S1 and S3 suggest
that p120RasGAP, p190RhoGAP, and PAK1 do not lie downstream of
pY361-Dok1, whereas data in Fig. S2 suggest that pY361-Dok1 may form
a ternary complex with both c-Abl and Nck1 to promote filopodia in
spreading MEFs. Fig. S1 shows that Dok1 did not coimmunoprecipitate
with p120RasGAP in spreading MEFs (A) and that tyrosine phosphorylation
of p190RhoGAP was similar among Abl
 / Arg
 / , Abl-, and KD-recon-
stituted MEFs spreading on FN (B). Fig. S2 shows that pY361-Dok1 coim-
munoprecipitated with Nck1 and c-Abl when all three proteins were
transiently expressed in 293T cells. Nck1 (A) and c-Abl (B) immunoprecip-
itates are shown. Fig. S3 shows PAK1 kinase activity was similar among
WT, Abl
 / Arg
 / , and Abl-reconstituted MEFs spreading on FN. Online
supplemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200312171.DC1.
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